We've recently received numerous requests from our membership looking for information on anticipated trends for CABG and valve procedures.
Read on to learn more our current forecasts for these procedures, as well as some insights on the productivity and practice portfolio of today’s cardiac surgeons.
Cardiac surgery volume projections: CABG to decline 3% over next five years
Late last week, the federal Food and Drug Administration’s (FDA’s) Circulatory System Devices panel voted unanimously to recommend approval of Cook Medical’s Zilver PTX drug-eluting stent (DES). If approved, the Zilver PTX would become the first DES available in the U.S. for the treatment of peripheral arterial disease (PAD) in the superficial femoral artery.
Novel Peripheral DES Passes Key FDA Test